Tuesday, July 10, 2007

First Skin Patch Sanctioned for Alzheimer's (HealthDay)



HealthDay - MONDAY, July 9 (HealthDay News) -- The Exelon skin patch
(rivastigmine transdermal system) has been approved by the U.S. Food and
Drug Administration to treat dementia associated with mild-to-moderate
Alzheimer's disease, maker Novartis Pharmaceuticals said Monday.

Source: http://rss.news.yahoo.com

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)